English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company
Patient Daily
| May 25, 2023
Lilly ESG Report Highlights Progress Towards Sustainability Goals
Patient Daily
| May 24, 2023
Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
Patient Daily
| May 22, 2023
Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Patient Daily
| May 9, 2023
Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
Patient Daily
| May 9, 2023
Lilly Declares Second-Quarter 2023 Dividend
Patient Daily
| May 9, 2023
Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
Patient Daily
| Apr 26, 2023
Lilly to Divest BAQSIMI to Amphastar
Patient Daily
| Apr 26, 2023
Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
Trending
+
Pharmaceuticals
Patient Daily
| Dec 17, 2024
Lung association warns against combined risks of smoking and radon
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
Discovery of replication hubs may lead to new antiviral therapies for norovirus
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
California student returns home after receiving life-saving heart transplant
Patient Daily
| Dec 23, 2024
Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
1
2
3
»
Last »